查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790271

美国伴侣动物感染疾病诊断市场规模、份额和趋势分析报告（按动物类型、感染类型、产品、技术、最终用途和细分市场预测，2025 年至 2033 年）

U.S. Companion Animal Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Infection Type (Bacterial, Viral, Parasitic), By Product, By Technology, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国伴侣动物感染疾病诊断市场概况

美国伴侣动物感染疾病诊断市场规模预计在 2024 年为 3.806 亿美元，预计到 2033 年将达到 6.353 亿美元，2025 年至 2033 年的复合年增长率为 6.02%。市场成长受到感染疾病病率上升、先进技术融合度提高、伴侣动物诊断设备监管批准增加以及该国官民合作关係不断加强等因素的推动。

美国伴侣动物诊断领域正透过先进技术与综合研究模式的结合，快速加速创新。兽医诊断领域的顶尖专家强调，人工智慧 (AI) 在从血液和尿液检查到影像平台和医疗记录系统等各个领域的变革中发挥着日益重要的作用。

像 Zoetis 的 Vetscan OptiCell 和 Imagyst 这样的人工智慧分析仪，能够在常规诊疗流程中更快、更准确地识别血球异常和病理变化。这些系统减少了变异性，减轻了兽医人员的工作量，同时为诊断决策提供即时支援。在诊断影像领域，经过数百万张 X 光和超音波影像训练的机器学习模型可以检测出猫狗扫描影像中的细微模式，提供接近人类的专业诊断效能和更快的周转时间。将人工智慧整合到记录保存、排程、自动化 SOAP 记录和趋势分析工具中，还可以简化诊疗管理，提高一致性，并使兽医能够专注于患者照护和客户沟通。

同时，「同一个健康」研究倡议，例如 2025 年 5 月德克萨斯A&M 大学和乔治亚大学关于犬南美锥虫病的合作研究，正在透过在动物/人类健康综合框架内解决通用感染疾病来重塑诊断重点。在最近超过 400 万美元的资助下，这些研发工作正在开发高灵敏度的诊断面板（基于 DNA 和血清学生物标记）、分期通讯协定和改进的治疗方法，以管理美国南部高风险犬群中的克氏锥虫感染疾病。透过监测私人宠物和工作犬，研究人员正在收集临床和生态学数据，以了解疾病进展、心臟影响和暴露途径，直接指导改进的诊断和早期疗育策略。 「同一个健康」方法确保犬隻诊断和治疗通讯协定的进步直接转化为流行地区的人类健康应用。

推动伴随诊断成长的其他趋势包括宠物照护日益复杂（宠物老化、合併症）、兽医部门的人力限制以及对快速可靠诊断结果日益增长的需求。互联互通和远端医疗工具使诊所能够利用云端基础的人工智慧平台、远端解释服务和决策支援系统，从而更有效率地做出更明智的临床决策。

总而言之，这些发展，例如能够提高速度和准确性的人工智慧诊断技术，加上一体化健康研发，正在推动伴侣动物诊断产业的发展。这些技术使兽医能够更早发现疾病，制定个人化治疗通讯协定，优化诊所运营，并使动物健康工作与更广泛的公共卫生目标保持一致。血液分析仪、影像人工智慧和疾病诊断流程等创新体现了跨科学、临床实践和各领域部门的合作如何推动美国精准兽医医学的新时代。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国伴侣动物感染疾病诊断市场的趋势与展望

  • 市场体系展望
    • 母市场
    • 子公司市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国伴侣动物感染疾病诊断市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析
    • 法律规范
    • 定价分析
    • 疾病流行分析
    • 以主要国家和物种估计的动物数量（2024 年）

第四章美国伴侣动物感染疾病诊断市场（依动物类型、估计和趋势分析）

  • 细分仪表板
  • 美国伴侣动物感染疾病诊断市场：动物类型变异分析
  • 美国伴侣动物感染疾病诊断市场规模及趋势分析（依动物类型），2021-2033
  • 狗
  • 猫
  • 马
  • 其他的

第五章美国伴侣动物感染疾病诊断市场技术、预测与趋势分析

  • 细分仪表板
  • 美国伴侣动物感染疾病诊断市场：技术变革分析
  • 美国伴侣动物感染疾病诊断市场规模及趋势分析（依技术划分）（2021-2033）
  • 免疫诊断
    • 横向流动化验
    • ELISA检测
    • 其他的
  • 分子诊断
    • 聚合酵素链锁反应（PCR）检测
    • 微阵列
    • 其他的
  • 其他的

第六章美国伴侣动物感染疾病诊断市场（依产品、估计和趋势分析）

  • 细分仪表板
  • 美国伴侣动物感染疾病诊断市场：产品差异分析
  • 2021-2033 年美国伴侣动物感染疾病诊断市场规模及趋势分析（依产品）
    • 耗材、试剂和套件
    • 设备和仪器

第七章美国伴侣动物感染疾病诊断市场：依感染疾病类型进行的估计与趋势分析

  • 细分仪表板
  • 美国伴侣动物感染疾病诊断市场：感染疾病类型波动分析
  • 美国伴侣动物感染疾病诊断市场规模及趋势分析（依感染疾病类型，2021-2033）
    • 细菌
    • 病毒
    • 寄生虫
    • 其他的

第八章美国伴侣动物感染疾病诊断市场最终用途、预测与趋势分析

  • 细分仪表板
  • 美国伴侣动物感染疾病诊断市场：最终用途变异分析
  • 美国伴侣动物感染疾病诊断市场规模及趋势分析（依最终用途），2021-2033
    • 兽医医院和诊所
    • 兽医参考实验室
    • 其他的

第九章 竞争态势

  • 市场参与企业分类
  • 企业市场分析/热图分析
  • 公司简介
    • IDEXX Laboratories Inc.
    • Zoetis Services LLC.
    • Antech Diagnostics, Inc.
    • Thermo Fisher Scientific, Inc
    • Virbac
    • bioMerieux SA
    • Neogen Corporation
    • IDVet
    • Agrolabo SpA
    • Bio-Rad Laboratories, Inc
  • 战略地图
    • 合併与收购
    • 伙伴关係和合作
    • 产品发布
    • 其他的
  • 其他主要角色列表
Product Code: GVR-4-68040-678-2

U.S. Companion Animal Infectious Disease Diagnostics Market Summary

The U.S. companion animal infectious disease diagnostics market size was estimated at USD 380.6 million in 2024 and is projected to reach USD 635.3 million by 2033, growing at a CAGR of 6.02% from 2025 to 2033. The market growth is fueled by factors such as the rising incidence of infectious diseases, the growing integration of advanced technologies, increasing regulatory approvals for companion animal diagnostic devices, and expanding public-private partnerships in the country.

In the U.S. companion animal diagnostics space, innovation is rapidly accelerating by combining advanced technologies and integrative research models. Leading experts in veterinary diagnostics emphasize that artificial intelligence (AI) plays an increasingly central role in transforming everything from bloodwork and urinalysis to imaging platforms and medical record systems.

AI powered analyzers such as Zoetis's Vetscan OptiCell and Imagyst enable faster, more accurate identification of blood cell abnormalities and pathological changes during routine clinic workflows. These systems reduce variability and lighten the workload on veterinary staff while delivering real time support for diagnostic decisions. In imaging, machine learning models trained on millions of x ray and ultrasound images can detect subtle patterns in canine and feline scans, offering near-human-expert diagnostic performance and much quicker turnaround times. AI integration into record keeping, scheduling, SOAP note automation, and trend analysis tools is also streamlining practice management, improving consistency, and freeing veterinarians to focus on patient care and client communication.

At the same time, One Health research initiatives, such as the May 2025 collaboration between Texas A&M and the University of Georgia on Chagas disease in dogs, are reshaping diagnostic priorities by tackling zoonotic infections within a combined animal/human health frame. Backed by over USD 4 million in recent funding, these researchers are developing sensitive diagnostic panels (DNA based and serologic biomarkers), staging protocols, and modified therapeutic regimens to manage Trypanosoma cruzi infection in canine cohorts at high risk in southern U.S. settings. By monitoring privately owned pets and working dogs, researchers are gathering clinical and ecological data to capture disease progression, cardiac impact, and exposure routes, feeding directly into improved diagnostics and early intervention strategies. The One Health approach ensures that advances in canine diagnostics and treatment protocols can directly inform human health applications in endemic regions.

Other converging trends fueling growth in companion diagnostics include the increasing complexity of pet care (pet aging, comorbidities), workforce constraints in the veterinary sector, and rising demand for rapid and trustworthy diagnostic results. With connectivity and telemedicine tools, clinics can leverage cloud based AI platforms, remote interpretation services, and decision support systems to make smarter clinical choices more efficiently.

To conclude, these developments, like AI enabled diagnostic technologies delivering heightened speed and accuracy, combined with integrative One Health research collaborations, are propelling the companion animal diagnostics industry forward. They enable veterinarians to detect disease earlier, personalize treatment protocols, optimize clinic operations, and align animal health efforts with broader public health goals. Innovations such as hematology analyzers, imaging AI, and disease diagnostic pipelines exemplify how science, clinical practice, and cross disciplinary collaboration drive a new era of precision veterinary medicine in the U.S.

U.S. Companion Animal Infectious Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. companion animal infectious disease diagnostics market report based on animal type, product, technology, Infection type, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Consumables, Reagents & Kits
  • Equipment & Instruments
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunodiagnostics
    • Lateral Flow Assays
    • ELISA Test
    • Others
  • Molecular Diagnostic
    • Polymerase Chain Reaction (PCR) Tests
    • Microarrays
    • Others
  • Others
  • Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Feline
  • Equine
  • Others
  • Infection Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Bacterial
  • Viral
  • Parasitic
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals and Clinics
  • Veterinary Reference Laboratories
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Country Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Companion Animal Infectious Disease Diagnostics Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence Of Infectious Diseases
      • 3.2.1.2. Growing Integration Of Advanced Technologies
      • 3.2.1.3. Increasing Regulatory Approvals For Companion Animal Diagnostic Devices
      • 3.2.1.4. Expanding Public-Private Partnerships In The Country
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of standardized regulations
      • 3.2.2.2. Lack of awareness in developing economies
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Companion Animal Infectious Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Disease Prevalence Analysis
    • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. U.S. Companion Animal Infectious Disease Diagnostics Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Companion Animal Infectious Disease Diagnostics Market: Animal Type Movement Analysis
  • 4.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by animal type, 2021 to 2033 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Equine
    • 4.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Companion Animal Infectious Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Companion Animal Infectious Disease Diagnostics Market: Technology Movement Analysis
  • 5.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by technology, 2021 to 2033 (USD Million)
  • 5.4. Immunodiagnostics
    • 5.4.1. Immunodiagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Lateral Flow Assays
      • 5.4.2.1. Lateral Flow Assays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. ELISA Test
      • 5.4.3.1. ELISA Test Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Molecular Diagnostic
    • 5.5.1. Molecular Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Polymerase Chain Reaction (PCR) Tests
      • 5.5.2.1. Polymerase Chain Reaction (PCR) Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Microarrays
      • 5.5.3.1. Microarrays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Companion Animal Infectious Disease Diagnostics Market: By Product Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Companion Animal Infectious Disease Diagnostics Market: By Product Movement Analysis
  • 6.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
    • 6.3.1. Consumables, Reagents & Kits
      • 6.3.1.1. Consumables, Reagents & Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Equipment & Instruments
      • 6.3.2.1. Equipment & Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Companion Animal Infectious Disease Diagnostics Market: By Infection Type, Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Companion Animal Infectious Disease Diagnostics Market: By Infection Type Movement Analysis
  • 7.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by Infection type, 2021 to 2033 (USD Million)
    • 7.3.1. Bacterial
      • 7.3.1.1. Bacterial Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Viral
      • 7.3.2.1. Viral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Parasitic
      • 7.3.3.1. Parasitic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Others
      • 7.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Companion Animal Infectious Disease Diagnostics Market: By End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Companion Animal Infectious Disease Diagnostics Market: By End Use Movement Analysis
  • 8.3. U.S. Companion Animal Infectious Disease Diagnostics Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
    • 8.3.1. Veterinary Hospitals and Clinics
      • 8.3.1.1. Veterinary Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Veterinary Reference Laboratories
      • 8.3.2.1. Veterinary Reference Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Others
      • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. IDEXX Laboratories Inc.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis Services LLC.
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Antech Diagnostics, Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Thermo Fisher Scientific, Inc
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Virbac
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. bioMerieux SA
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Neogen Corporation
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. IDVet
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Agrolabo S.p.A.
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Bio-Rad Laboratories, Inc
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Product launch
    • 9.4.4. Others
  • 9.5. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Companion animal infectious disease diagnostics Market, by Animal type, 2021 - 2033 (USD Million)
  • Table 3 U.S. Companion animal infectious disease diagnostics Market, by Infection Type, 2021 - 2033 (USD Million)
  • Table 4 U.S. Companion animal infectious disease diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 5 U.S. Companion animal infectious disease diagnostics Market, by Product, 2021 - 2033 (USD Million)
  • Table 6 U.S. Companion animal infectious disease diagnostics Market, by End use, 2021 - 2033 (USD Million)
  • Table 7 Company Overview
  • Table 8 Product Benchmarking
  • Table 9 Financial Performance
  • Table 10 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Companion animal infectious disease diagnostics Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. Companion animal infectious disease diagnostics Market snapshot
  • Fig. 11 U.S. Companion animal infectious disease diagnostics Market driver impact
  • Fig. 12 U.S. Companion animal infectious disease diagnostics Market restraint impact
  • Fig. 13 U.S. Companion animal infectious disease diagnostics animal type key takeaways (USD Million)
  • Fig. 14 U.S. Companion animal infectious disease diagnostics Market: animal Type movement analysis
  • Fig. 15 Canine market, 2021 - 2033 (USD Million)
  • Fig. 16 Feline market, 2021 - 2033 (USD Million)
  • Fig. 17 Equine market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Companion animal infectious disease diagnostics Market Product key takeaways (USD Million)
  • Fig. 20 U.S. Companion animal infectious disease diagnostics Market: product movement analysis
  • Fig. 21 Consumables, Reagents & Kits market, 2021 - 2033 (USD Million)
  • Fig. 22 Equipment & Instruments market, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Companion animal infectious disease diagnostics Market Technology key takeaways (USD Million)
  • Fig. 24 U.S. Companion animal infectious disease diagnostics Market: Technology movement analysis
  • Fig. 25 Immunodiagnostics market, 2021 - 2033 (USD Million)
  • Fig. 26 Lateral Flow Assays market, 2021 - 2033 (USD Million)
  • Fig. 27 ELISA Test market, 2021 - 2033 (USD Million)
  • Fig. 28 Others market, 2021 - 2033 (USD Million)
  • Fig. 29 Molecular Diagnostic market, 2021 - 2033 (USD Million)
  • Fig. 30 Polymerase Chain Reaction (PCR) Tests market, 2021 - 2033 (USD Million)
  • Fig. 31 Microarrays market, 2021 - 2033 (USD Million)
  • Fig. 32 Others market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Companion animal infectious disease diagnostics Market Infection type key takeaways (USD Million)
  • Fig. 34 U.S. Companion animal infectious disease diagnostics Market: Infection Type movement analysis
  • Fig. 35 Bacterial market, 2021 - 2033 (USD Million)
  • Fig. 36 Viral market, 2021 - 2033 (USD Million)
  • Fig. 37 Parasitic market, 2021 - 2033 (USD Million)
  • Fig. 38 Others market, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Companion animal infectious disease diagnostics Market by End Use key takeaways (USD Million)
  • Fig. 40 U.S. Companion animal infectious disease diagnostics Market: by End Use movement analysis
  • Fig. 41 Veterinary Reference Laboratories market, 2021 - 2033 (USD Million)
  • Fig. 42 Veterinary Hospitals and Clinics market, 2021 - 2033 (USD Million)
  • Fig. 43 Others market, 2021 - 2033 (USD Million)
  • Fig. 44 Market participant categorization